Ovarian cancer Archives

Promising potential treatment for ovarian cancer reaches final stages of clinical trials

Written by

Dr Richard Penson and VBL Therapeutics are developing a new anti-ovarian cancer gene therapy treatment, VB-111

Ovarian cancer is one of the most dangerous forms of cancer. A treatment approach using platinum-based chemotherapy compounds is commonly used, however some tumour cells are resistant to the drugs used in this process. VBL Therapeutics is developing a promising new anti-cancer gene therapy: VB-111. With its unique dual mode of action, it targets the tumour environment by disrupting the […]

Novel cancer therapeutics could target ion channels

Written by

Although gynaecological cancers are amongst the most lethal cancers in women, treatments for the advanced stages of these cancers are scarce. Dr Saverio Gentile at the University of Illinois Cancer Center has been researching potassium ion channels as a potential target for novel cancer therapeutics. He has found that the use of potassium channel activators greatly reduced cell motility, tumour […]

Exciting advancements in ovarian cancer treatment

Written by

Ovarian cancer is treacherous and challenging to treat. With standard treatment unchanged since the 1990s and newer costly treatments failing to restrain the tumour’s growth over long periods of time, an overhaul in anti-cancer treatment is urgently needed. With fresh insights into the biology and progression of ovarian cancer, Lev Ashraphyan, Vsevolod Kiselev from Institute of Gynecologic Oncology and Mammology […]